Since MTHFR polymorphisms may affect sensitivity to MTX and their frequency may differ by ethnicity, we evaluated these polymorphisms in a group of Egyptian pediatric ALL patients on methotrexate-based maintenance treatment to determine the respective genotype frequencies and their impact on MTX toxicity. The gene discussed is MTHFR; the disease is acute lymphoblastic leukemia.